Revision Year: 2014 Publisher: GUERBET, BP 57400 F-95943 Roissy CDG Cedex, France Manufacturing site address: GUERBET, 16-24 rue Jean Chaptal, 93600 Aulnay-sous-Bois, France
This medicinal product is for diagnostic use only.
Contrast agent for use in:
| Xenetix 250 | Xenetix 300 | Xenetix 350 |
|---|---|---|
| Intravenous digital subtraction angiography | Intravenous urography, Intravenous digital subtraction angiography, Arthrography, Hysterosalpingography | Intravenous urography, Intravenous digital subtraction angiography |
The doses must be adapted to the examination and the regions to be opacified, as well as to the body weight and renal function of the subject.
There is no data about the use of Xenetix in pediatric patients. Therefore, the use of Xenetix is not recommended in pediatric patients.
Usually the same iodine concentration and volume are used as with other iodinated X-ray contrast in current use. As with all contrast media, the lowest dose necessary to obtain adequate visualisation should be used.
Adequate hydration should be assured before and after administration as for other contrast media.
Usually, the rate of administration varies between 0.5 and 5 ml/s depending on the type of examination.
Xenetix 250 – Recommended mean dosages for intravascular routes:
| Indications | Mean dose (ml/kg) | Total volume range (ml) |
|---|---|---|
| Intravenous digital subtraction angiography | 3.1 | 75-360 |
Xenetix 300 – Recommended mean dosages for intravascular routes:
| Indications | Mean dose (ml/kg) | Total volume range (ml) |
|---|---|---|
| Urography with: | ||
| rapid i.v. injection | 1.2 | 50-100 |
| slow i.v. injection | 1.6 | 100 |
| Intravenous digital subtraction angiography | 1.7 | 40-270 |
Xenetix 300 – Recommended mean dosages for intracavitary routes:
| Indications | Mean volume (ml) | Comments |
|---|---|---|
| Arthrography | 5 to 20 | Intraarticular route Volume adapted to the joint |
| Hysterosalpingography | 5 to 20 | Intrauterine route Dose to be adapted to the uterine volume |
Xenetix 350 – Recommended mean dosages for intravascular routes:
| Indications | Mean dose (ml/kg) | Total volume range (ml) |
|---|---|---|
| Intravenous urography | 1.0 | 50-100 |
| Intravenous digital subtraction angiography | 2.1 | 95-250 |
If a very high dose of contrast agent is administered, the water and electrolyte loss must be compensated by suitable rehydration. Renal function must be monitored for at least three days. Haemodialysis may be performed if necessary.
Three years.
Keep out of the reach and sight of children.
Vials/bottles: Do not store above 30°C and protect from light.
Do not use after the expiry date given on the vial.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
